ERBB2 and breast cancer: Patients with HER2+ breast cancer, especially the non-luminal cases, have a poorer prognosis, similar to TNBC, with higher histological tumor grades, higher rates of recurrence, and more frequent distant metastases to bone, liver, lung, and brain than patients with luminal breast cancer [9,10,11,12,13].